"Advanced solid tumor" trang 1 - tải miễn phí từ tailieunhanh
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
13    35    1
Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: A 3-year retrospective study

Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: A 3-year retrospective study
7    74    1
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
10    55    1
Enhancement of electrical properties of NASICON-type solid electrolytes (LiSn2P3O12) via aluminium substitution

Enhancement of electrical properties of NASICON-type solid electrolytes (LiSn2P3O12) via aluminium substitution
10    61    1
Highly conducting solid electrolyte films based on PVA and iron alum: Synthesis, characterization and electrical properties

Highly conducting solid electrolyte films based on PVA and iron alum: Synthesis, characterization and electrical properties
9    37    1
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: A phase 1 dose-escalation trial
7    38    1
Photoluminescence and photometric studies of low temperature prepared red emitting MgAl2O4:Cr3+ nanophosphors for solid state displays

Photoluminescence and photometric studies of low temperature prepared red emitting MgAl2O4:Cr3+ nanophosphors for solid state displays
7    27    1
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours

Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
9    30    1
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
12    40    1
Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors

Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors
12    4    1
A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
10    64    1
Advanced characterization of regioselectively substituted methylcellulose model compounds by DNP enhanced solid-state NMR spectroscopy

Advanced characterization of regioselectively substituted methylcellulose model compounds by DNP enhanced solid-state NMR spectroscopy
9    8    1
Báo cáo y học:

Báo cáo y học: "Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors"
7    73    0
Mechanical properties of solid polymers Constitutive modelling of long and short term behaviour

Mechanical properties of solid polymers Constitutive modelling of long and short term behaviour
155    79    0
A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer

A phase Ib study of capecitabine and zivaflibercept followed by a phase II singlearm expansion cohort in chemotherapy refractory metastatic colorectal cancer
9    85    0
Algorithms for visual design using the processing language: Part 2

Algorithms for visual design using the processing language: Part 2
203    46    1
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
6    27    1
Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
10    53    1
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
8    46    1
The effect of different dosing regimens of motesanib on the gallbladder: A randomized phase 1b study in patients with advanced solid tumors

The effect of different dosing regimens of motesanib on the gallbladder: A randomized phase 1b study in patients with advanced solid tumors
11    43    1